menu
    • menu

    Company profile for OcuMension Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Oerlikon Bio is a Chinese ophthalmology platform company dedicated to identifying, developing and commercializing the first or best ophthalmology therapy of its kind. Our vision is to provide a world-class overall drug solution to meet the huge demand gap in China's ophthalmology medical care. Since its establishment, we have been focusing on building an ophthalmic medicine platform that integrates the full-cycle professional ...
    Oerlikon Bio is a Chinese ophthalmology platform company dedicated to identifying, developing and commercializing the first or best ophthalmology therapy of its kind. Our vision is to provide a world-class overall drug solution to meet the huge demand gap in China's ophthalmology medical care. Since its establishment, we have been focusing on building an ophthalmic medicine platform that integrates the full-cycle professional capabilities of ophthalmic drug development from R&D, manufacturing to commercialization. We believe that our platform puts us in a favorable position on the road to becoming a leader in China's ophthalmology industry

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    OcuMension TherapeuticsChina Flag
    Country
    Country
    China
    Address
    Address
    Room 502-1, Wangwang Building, No. 211 Shimen 1st Road, Jing'an District, Shan...
    Telephone
    Telephone
    +86 (021)-61493800
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ocumension.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Nicox & Kowa Sign €191.5M Deal for NCX 470 Rights
    Nicox & Kowa Sign €191.5M Deal for NCX 470 Rights

    17 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/17/3116959/0/en/Nicox-and-Kowa-Sign-Key-Agreement-worth-up-to-191-5-million-for-Exclusive-Rights-to-Glaucoma-Treatment-NCX-470-in-U-S-and-all-Unlicensed-Territories.html

    GLOBENEWSWIRE
    17 Jul 2025
    Share Share
    OcuMension Acquires Alcon Eye Drops Rights For 16.7% Equity Stake
    OcuMension Acquires Alcon Eye Drops Rights For 16.7% Equity Stake

    12 Aug 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ocumension-acquires-rights-to-alcon-eye-drops-in-exchange-for-a-16-7-equity-stake-signaling-the-commencement-of-comprehensive-strategic-relationship-302219955.html

    PR NEWSWIRE
    12 Aug 2024
    Share Share
    Ocumension Shows Strong Resilience And Commercialization Growth
    Ocumension Shows Strong Resilience And Commercialization Growth

    12 Aug 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ocumension-01477hk-demonstrates-strong-operational-resilience-commercialization-capabilities-reach-new-heights-302219944.html

    PR NEWSWIRE
    12 Aug 2024
    Share Share
    China approves treatment for chronic non-infectious eye inflammation
    China approves treatment for chronic non-infectious eye inflammation

    23 Jun 2022

    // BIOSPECTRUMASIA

    https://www.biospectrumasia.com/news/25/20560/china-approves-treatment-for-chronic-non-infectious-eye-inflammation.html

    BIOSPECTRUMASIA
    23 Jun 2022
    Share Share
    In a first, China approves eye implant based solely on RWD
    In a first, China approves eye implant based solely on RWD

    22 Jun 2022

    // Nick Paul Taylor FIERCEPHARMA

    https://www.fiercepharma.com/pharma/first-china-approves-eye-implant-based-solely-real-world-data

    Nick Paul Taylor FIERCEPHARMA
    22 Jun 2022
    Share Share
    Ocumension Therapeutics Announces 2021 Interim Results
    Ocumension Therapeutics Announces 2021 Interim Results

    20 Aug 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/ocumension-therapeutics-announces-2021-interim-results-301359820.html

    PRNEWSWIRE
    20 Aug 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search